PRI has discovered and served as an incubator for a number of technologies and pharmaceutical projects that subsequently were licensed to development partners or incorporated into PRI portfolio companies.                    

Adamas Pharmaceuticals Inc
CytoMag LLC
Dyax Inc
Extend Pharma LLC
Fibralign Corp
Galaxy Biotech LLC
Igenex Inc
Integrigen Inc
Kalobios Inc
Larix BioScience LLC
Life Science Angels Inc
Lucidant Polymers Inc
MagArray Inc
PanoLife Products Inc
Panorama Institute of Molecular Medicine
Planet Biotechnology Inc
Quality Control Labs Inc
NuGen Technologies Inc
Quantagen Inc
Regenerative Sciences Institute
Theron Pharmaceuticals Inc
TransTarget Inc
Velocity Pharmaceutical Development LLC
Vitesse Biologicals LLC
WntGen LLC
Xagros Inc